Work

A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis

Year: 2022

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(22)00663-8

Authors: Timothy Morgan, Aliya Asghar, John Tayek, Danh Nguyen, M.Wayn Fleischman, John Donovan, Joseph Alcorn, Daniel Chao, Andrew Stolz

Institutions: University of California, Irvine, VA Long Beach Healthcare System, The Lundquist Institute, Harbor–UCLA Medical Center, LAC+USC Medical Center, University of New Mexico, Raymond G. Murphy VA Medical Center, VA Loma Linda Healthcare System

Language: English

Topic: Alcohol Consumption and Health Effects

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4283821755

FWCI: 0.167

Cites: 16

Cited by: 1

Related to: 10